This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BIO-Europe Spring

€500 savings end in:

  • 00
  • 00
  • 00
  • 00
March 18–20, 2024 | Barcelona, SpainMarch 26–27, 2024 | Digital Partnering

Four Guardians. Pty Ltd


Four Guardians, has discovered and advanced to develop an important drug target for the HIV/AIDS pandemic for 2nd and 3rd world countries. It is a Protease Inhibitor DG 17 Prodrug. The plan it to form a US New Corp in San Diego (There is no market in Australia we have a very small infected population) – The IP is valued independently at 189 million, this would be transferred in a US New Corp. Possible you could help us to seek grants on our behalf. We are out to raise 6 to 8 M to complete clinical trials in Mexico, as MoH registration would be a stepping stone, we would then in 2.5 years have the ability to enter the larger world markets.